Moreover, SGLT2-i use increased the risk for DKA in patients with DM microvascular complications (HR 2.044; 95% CI 0.900–4.640; p value 0.088) and in those prescribed diuretics (HR 3.648; 95% CI 0.720–18.480; p value 0.118), although this was not statistically significant [58]. Here, SLC5A2 is linked to diabetes mellitus.